top of page

How Do We Check the Safety of Psychiatric Medications for Breastfeeding Moms?

How Do We Check the Safety of Psychiatric Medications for Breastfeeding Moms?

Checking if psychiatric meds are safe for breastfeeding involves looking at a mix of drug data, real-life results, and expert advice. Here’s what goes into it:


Close-up of a woman breastfeeding a newborn, her hand gently supporting the baby's head. Soft lighting, blue and white tones. Calm mood.
A tender moment captured as a mother cradles her newborn during feeding, showcasing the warmth and closeness of their bond.

  • Measured Drug Levels: Researchers look at how much of the drug is in mom's blood, breast milk, and sometimes the baby's blood. If the baby's blood shows little to no drug even when it's in the milk, that's a good sign for safety.


  • Milk-to-Plasma (M/P) Ratio: This number shows how much of the drug moves from mom’s blood to her milk. You get it by dividing the drug amount in milk by the amount in blood. If this ratio is less than 1, it usually means not much drug is getting into the milk, which is good news.


  • Relative Infant Dose (RID): RID takes into account the M/P ratio and the weights of both mom and baby to estimate how much drug the baby is getting from the milk. If this dose is less than 10% of what mom takes (adjusted for weight), it's reassuring.


  • Case Series & Adverse Event Reports: Doctors look at reports and studies on any side effects in babies, like sleepiness or feeding problems. They check how often these happen and how serious they are compared to how many babies were exposed.


  • Consensus and Guidelines: Groups like the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and LactMed regularly update their advice based on all the data and real-world experiences.


To make sense of it all, Uguz has come up with a safety scoring system that rates how safe these meds are for breastfeeding. It looks at things like the number of studies, the highest RID, baby blood levels, and any reported side effects. The score goes from 0 to 10, with higher numbers meaning better safety and more confidence in using the meds while breastfeeding.


This detailed approach helps doctors and moms decide together on using psychiatric meds during breastfeeding, finding a balance between the benefits for mom’s mental health and the safety of the baby.


Like, Share, Follow and Subscribe for more original content by Tally Reproductive Psychiatrist, Jamie Lee Sorenson, MD on Women’s Mental Health and the Bendy Boy Mom life.



Taking new patients in FL, GA, CO, and TN. All patients 12 years and older are welcome.



Disclaimer: Posts are for education and entertainment only. No medical advice given. This information is for general knowledge and not meant to diagnose or treat any conditions.




Comments


Tally Reproductive Psychiatrist, LLC

Private Practice of Jamie Sorenson, MD

3689 Coolidge Court Unit 5

Tallahassee, FL 32311

Call or Text: 850-694-2008

Fax: (786) 590-1485

Email: info@tallyrepropsych.com

Online Scheduling:

https://tallyrepropsych.clientsecure.me/

  • Youtube
  • Instagram
  • Threads
  • TikTok
  • Facebook
  • Linkedin

Telemedicine appointments available only in: Florida, Georgia, Tennessee, Colorado, and Massachusetts

If you are experiencing thoughts of self-harm or are in crisis, please do not use this website. Instead, call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency department. If you are outside the United States, please contact your local emergency number.

Conditions Dr. Sorenson has expertise in:

  • Attention Deficit Hyperactivity Disorder (ADHD)

  • Autism Spectrum Disorder (ASD)

  • Obsessive Compulsive Disorder (OCD)

  • Depression or Major Depressive Disorder (MDD)

  • Anxiety or Generalized Anxiety Disorder (GAD)

  • Panic Disorder with and without agorophobia

  • Bipolar Disorder

  • Bipolar 2 Disorder

  • Post Traumatic Stress Disorder (PTSD)

  • Chronic Post Traumatic Stress Disorder (CPTSD)

  • Premenstrual Dysphoric Disorder (PMDD) or Premenstrual Exacerbation of a mood disorder (PME)

  • Perinatal Depression and Postpartum Depression

  • Perinatal Anxiety and Postpartum Anxiety

  • Perinatal OCD and Postpartum OCD

  • Perinatal Psychosis and Postpartum Psychosis

  • Perimenopause/Menopause Mood and Anxiety Disorders

  • Perimenopause/Menopause Cognitive Disorders

  • Gender Dysphoria

  • LGBTQI Mental Health

  • Mood and anxiety disorders while undergoing infertility treatments

Comorbidities not directly treated by Dr. Sorenson that will routinely be considered in your individualized treatment plan and recommendations:

  • Ehlers-Danlos Syndrome

  • Hypermobility Spectrum Disorders

  • Mast Cell Activation Syndrome (MCAS)

  • Postural Orthostatic Tachycardia Syndrome (POTS), dysautonomia, and Mitral Valve Prolapse

  • Fibromyalgia 

  • Chronic Pain

  • Chronic Fatigue Syndrome (CFS)

  • Insomnia and Sleep Apnea

  • Narcolepsy and Idiopathic Hypersomnia

  • Chiari Malformation

  • Small Fiber Neuropathy

  • Pelvic organ prolapse, incontinence, chronic pelvic pain, pelvic floor dysfunction, hernias

  • Irritable Bowel Syndrome (IBS), gastroparesis, gut dysmotility

  • Bladder Pain Syndrome (previously interstitial cystitis)

  • Osteoporosis/Osteopenia

  • Dental Problems/TMJ

  • Migraines and Headaches​

  • Hormone Replacement Therapy (HRT)

  • Infertility Treatment

  • Endometriosis 

  • Polycystic Ovarian Syndrome (PCOS), Now Polyendocrine Metabolic Ovarian Syndrome (PMOS)

  • Thyroid Disorders: Hypothyroidism and Hyperthyroidism

  • Raynaud's Disease

  • Autoimmune disorders: Lupus (SLE), Sjogren's Syndrome, Hashimoto's thyroiditis and Grave's DiseaseCREST SyndromeSclerodermaCeliac Disease and Ulcerative Colitis (UC)Psoriasis/Psoriatic ArthritisRheumatoid Arthritis (RA), Multiple Sclerosis (MS) and Neuromyelitis optica (NMO)

bottom of page